Chan A, Cohan S, Stark J, et al. Treatment with delayed-release dimethyl fumarate is associated with fewer relapses versus glatiramer acetate in patients with relapsing remitting multiple sclerosis: real-world comparative effectiveness analyses from the EFFECT study. ECTRIMS 2017, P1160.
Biobank ideale bron voor onderzoek naar COVID-19
sep 2020 | Dementie, Multipele Sclerose, Neuro-musculair